Short bioregulator peptide supporting vascular endothelial function.
TL;DR — Vesugen is a recovery & repair peptide with a typical starting dose of 2 mg. For a 20 mg vial, add 2 mL bacteriostatic water to yield 10 mg/mL.
Add 2 mL of bacteriostatic water to a 20 mg vial, injecting slowly down the inside wall. Swirl gently; never shake. This yields a concentration of 10 mg/mL.
What is the recommended dose of Vesugen?
A typical research dose is 2 mg. Consult the ASCEND calculator for your specific vial concentration and draw volume.
How many doses are in a Vesugen vial?
A 20 mg vial reconstituted with 2 mL BAC water yields approximately 10 doses at 2 mg each.
Peptide Intelligence
What is Vesugen and what does it target?
Vesugen is a short bioregulator peptide (Lys-Glu-Asp) targeting vascular endothelial cells. It is researched for improving vascular tone, endothelial function, and microcirculatory health, developed by the St. Petersburg Institute of Bioregulation.
What is the typical research protocol for Vesugen?
Vesugen is typically used in short course protocols of 10–30 days via subcutaneous injection at 1–2 mg per dose. It is sometimes cycled with Epithalon or Thymalin in anti-aging research stacks based on the original Russian bioregulator protocols.
How does Vesugen differ from other cardiovascular peptides?
Unlike ARA-290 or SS-31, which have specific receptor targets, Vesugen is a bioregulator peptide believed to work by epigenetic modulation of gene expression in vascular tissues. It is part of the Russian peptide bioregulator class developed by Khavinson.